🔎 Trials Near Me

ホーム › 肥満症 › ネブラスカ州

ネブラスカ州における肥満症の臨床試験

ネブラスカ州内の拠点で、肥満症に関する10件の研究が参加者を募集しています。

ネブラスカ州内の都市

公式研究テキスト（英語）

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • University Of Nebraska Medical Center, Omaha
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Omaha Childrens Hospital, Omaha
  • Velocity Clinical Research, Omaha
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Omaha
  • Research Site, Omaha
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Bryan Heart, Lincoln
  • University of Nebraska Medical Center, Omaha
  • Primary Clinical Research, Papillion
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Bryan Heart, Lincoln
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Omaha
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Lincoln
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Bryan Heart, Lincoln
  • Velocity Clinical Research Lincoln, Lincoln
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Omaha
被験者募集中第3相
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  • Velocity Clinical Research - Omaha, Omaha
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/07/22更新 · NCT07477704

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。